Evidence map›Paper›PMID 40456913›Full record

ArticleScientific reports2025

Artistic anti-counterfeiting with a pH-responsive fluorescent ink using DFT and molecular electrostatic potential mapping insights.

Hebat-Allah S Tohamy

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. RSC advances · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hebat-Allah S TohamyCellulose and Paper Department, National Research Centre, 33 El Bohouth Str., P.O. 12622, Dokki, Giza, Egypt. hebasarhan89@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The observed fluorescence behavior of the sulfur, nitrogen-doped carbon dots (S, N-CDs) ink which derived from onion peel wastes (OW) demonstrates its pH-sensitive nature, making it suitable for applications where visual or fluorescent changes upon pH variation are desired. The initial lack of fluorescence under UV light suggests that the S, N-CDs in the ink are in a non-fluorescent state. However, upon treatment with acid, the ink exhibits a faint yellow color under light and fluoresces under UV light. This indicates a shift in the electronic structure of the S, N-CDs, likely due to protonation. The return to non-fluorescence after re-treatment with alkaline solution suggests that the de-protonation process reverses the effect of acid, restoring the S, N-CDs to their original non-fluorescent state. This reversible pH-sensitivity is a valuable asset for various applications. The synthesized S, N-CDs exhibited a reversible change in fluorescence intensity under acidic and alkaline conditions, transitioning from non-fluorescent to fluorescent under acidic conditions and back to non-fluorescent in alkaline media. Density Functional Theory (DFT) calculations revealed that S, N-doping resulted in a narrower energy gap (0.2779 eV compared to 0.3199 eV for N-CDs) and a higher dipole moment (2.640 Debye), enhancing their reactivity towards protons and leading to more pronounced color and fluorescence changes across different pH conditions. The S, N-CDs displayed dual fluorescence emission peaks at 443.00 nm and 502.00 nm upon excitation at 350 nm, and fluorescence contour maps (FCM) confirmed their multicolor emission capabilities. The calculated quantum yield for the S, N-CDs was notably high at 37.76%. Fourier Transform Infrared (FTIR) spectroscopy confirmed the successful incorporation of sulfur (S-H at 2368 cm⁻

Indexed as

Anti-counterfeitingArtistic inkDFTFluorescent inkOnion peelspH-sensitive inkSecurity ink

Identifiers

PMID40456913
PMCPMC12130523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.